Loading company…
vTv Therapeutics Inc., based in North Carolina, develops diabetes treatments and was acquired in February 2024 for about USD 51 million.
Established in 2015 and based in North Carolina, US, vTv Therapeutics Inc. develops biopharmaceutical products for diabetes treatment. In February 2024, JDRF T1D Fund and Samsara BioCapital acquired the company for approximately USD 51 million through a PIPE transaction. Its pipeline includes TTP399, HPP737 and TTP273, and Paul Sekhri is CEO as of 2024.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in